US › Healthcare

ICON PLC (ICLR)

US · Healthcare · Diagnostics & Research

$156.85-0.98%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$2.06B

Revenue YoY

+2.3%

Net profit

$72.6M

Profit YoY

-60.3%

EPS

$2.35

EPS estimate

$2.26

Net margin

3.5%

EPS came in at 2.35 against a street estimate of 2.26 — a beat of 4.0%.

Key statistics

Market cap

$12.62B

P/E

251.6

Forward P/E

15.6

P/B

1.35

Book value

$121.41

EPS (TTM)

$0.65

52-week high

$203.91

52-week low

$66.57

50-day MA

$154.96

200-day MA

$148.25

Beta

1.22

Analyst view

Analysts rate ICON PLC a buy (11 buy, 6 hold, 0 sell out of 17) with an average price target of $185.56.

Shareholding

Insiders

0.43%

Institutions

108.05%

Largest institutional holders

Fund	Stake
Artisan Partners Limited Partnership	10.73%
Wellington Management Company LLP	7.66%
Harris Associates L.P.	5.64%
FMR Inc	5.41%
Amvescap Plc.	5.03%
Principal Financial Group Inc	4.29%
Greenhaven Associates Inc	4.02%
Brave Warrior Advisors LLC	3.88%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for ICON PLC — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.